From the TMS Board > Board News > 2005 Board News > Meet our New Medical Advisory Board
Meet our New Medical Advisory Board
February 22, 2005
- Valerie Slee, Vice-Chair, Board of Directors
The Mastocytosis Society is pleased to announce that we have assembled a wonderful group of physicians and researchers to serve on our brand new Medical Advisory Board. We were assisted in our initial efforts to assemble such a board by our good friends at Critical Therapeutics, Rick Finnegan and Joanne Meisner, who actually suggested the idea of an MAB to us! We sent out invitations trying to cover physicians in many of the core disciplines that relate to mast cell diseases, and we gratefully received the following positive responses!
Our new board includes:
Dr. Cem Akin
University of Michigan, Ann Arbor, MI
Dr. Frank Austen - Honorary member
Brigham and Women's Hospital, Chestnut Hill, MA
Dr. Joseph Butterfield
Mayo Clinic Rochester, MN
Dr. Mariana Castells
Brigham and Women's Hospital, Chestnut Hill, MA
Dr. Luis Escribano
Hospital Ramon y Cajal, Spain
Dr. Richard Horan
Brigham and Women’s Hospital, Chestnut Hill, MA
Dr. Dean Metcalfe
NIAID/ NIH
Dr. Philip Miner
University of Oklahoma
Dr. Chad Oh
UCLA School of Medicine, Los Angeles, CA
Dr. Theoharis Theoharides
Tufts University, Boston, MA
Dr. Peter Valent
University of Vienna, Austria
Dr. Srdan Verstovsek
MD Anderson Cancer Center, Houston, TX
The Medical Advisory Board will help review research material, will confer with other doctors and researchers, and will help up determine the overall direction of the organization. Regis Park, Research Chair, will serve as the MAB liaison to the TMS Board. While we cannot afford to pay for expenses for MAB members to attend the annual meeting at this time, that is certainly something we hope can be done in the future. Many of these physicians have attended the annual meetings on their own, either as speakers of participants, and we look forward to working with them on an ongoing basis. If you are a patient of any of these MAB members, please thank them for their volunteer commitment to TMS! And many thanks to Regis (Gigi) Park and her research committee members, for offering to take on even more work and to Critical Therapeutics, for helping us to launch this new endeavor.